13F Data
13F filer · CIK 2005245

Siren, L.L.C.

New York, NY · filing since Q3 2024 · last filing Aug 13, 2026
Reported value
$4.9B
+$1.3B vs prior
Positions
117
New / sold out
27 / 10
Added / reduced
31 / 21
Turnover
11.0%
buys $824.1M · sells $469.7M
Top-10 weight
44.6%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewParabilis Medicines Inc+2,992,259–+$81.9M
NewAbivax SA+576,000–+$76.8M
NewHemab Therapeutics Holdings Inc+2,086,834–+$76.6M
NewRelay Therapeutics Inc+3,650,000–+$68.3M
AddedEnliven Therapeutics Inc+1,028,185+137.8%+$52.2M
NewKailera Therapeutics Inc+2,214,286–+$48.8M
AddedRhythm Pharmaceuticals Inc+410,764+56.6%+$45.6M
NewCapital One Finl Corp+171,615–+$34.4M
NewOruka Therapeutics Inc+250,000–+$23.8M
NewSeaport Therapeutics Inc+1,095,316–+$23.8M
48 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedScholar Rock Holding Corp-1,250,000-11.5%$-68.8M
ReducedEdgewise Therapeutics Inc-1,245,634-28.1%$-50.6M
Sold outCentessa Pharmaceuticals PLC-1,053,464-100.0%$-41.8M
ReducedRevolution Medicines Inc-210,980-19.0%$-39.5M
Sold outenGene Holdings Inc-5,253,159-100.0%$-35.8M
ReducedKymera Therapeutics Inc-251,000-7.9%$-28.8M
ReducedStructure Therapeutics Inc-455,731-34.3%$-24.5M
ReducedArcus Biosciences Inc-586,647-19.5%$-18.1M
ReducedCrinetics Pharmaceuticals Inc-482,848-25.4%$-18.1M
Sold outFulcrum Therapeutics Inc-2,350,000-100.0%$-18.0M
21 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q3 2024: $2.0BQ4 2024: $2.3BQ1 2025: $1.8BQ2 2025: $1.9BQ3 2025: $2.6BQ4 2025: $3.4BQ1 2026: $3.6BQ2 2026: $4.9B
Q3 2024Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1Scholar Rock Holding CorpCOM9,575,013$526.6M10.66%
2Kymera Therapeutics IncCOM2,935,830$336.7M6.81%
3Erasca IncCOM11,397,781$208.8M4.23%
4Veradermics IncCOMMON STOCK1,655,374$203.5M4.12%
5Tango Therapeutics IncCOM6,179,364$193.2M3.91%
6Revolution Medicines IncCOM900,000$168.6M3.41%
7Bicara Therapeutics IncCOM5,602,970$166.4M3.37%
8Arrowhead Pharmaceuticals IncCOM1,715,476$139.8M2.83%
9BeOne Medicines AGSPONSORED ADS465,000$132.5M2.68%
10Edgewise Therapeutics IncCOM3,184,629$129.4M2.62%
107 more rows. Subscribe for $29/month to see every row, download the data and use the API.